Medtronic (MDT) Total Non-Current Liabilities (2014 - 2026)
Medtronic (MDT) reported Total Non-Current Liabilities of $41.4 billion for Q2 2026, down 0.51% on a YoY basis from $41.7 billion in Q2 2025, and up 2.28% sequentially from $40.5 billion in Q1 2026.
Medtronic (MDT) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends
Medtronic (MDT) has 13 years of Total Non-Current Liabilities data on file, last reported at $41.4 billion in Q2 2026.
- For the quarter ending Q2 2026, Total Non-Current Liabilities fell 0.51% year-over-year to $41.4 billion; the trailing twelve-month figure through Apr 2026 stood at $41.4 billion (down 0.51% YoY), and the FY2026 full-year result was $41.4 billion, down 0.51% from the prior year.
- Total Non-Current Liabilities climbed to $41.4 billion in Q2 2026, from $40.5 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $41.7 billion in Q2 2025 to a low of $36.2 billion in Q2 2022.
- A 5-year average of $39.0 billion and a median of $39.3 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities dropped 14.54% in 2022 and rose 9.06% in 2025, its largest moves.
- Tracing MDT's Total Non-Current Liabilities over 5 years: stood at $40.8 billion in 2022, then fell by 10.22% to $36.7 billion in 2023, then grew by 8.53% to $39.8 billion in 2024, then advanced by 2.91% to $41.0 billion in 2025, then grew by 1.2% to $41.4 billion in 2026.
- Business Quant data shows MDT's Total Non-Current Liabilities at $41.4 billion in Q2 2026, $40.5 billion in Q1 2026, and $41.0 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 3.47 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 24, 2026 | 41.44 Bn |
| Jan 23, 2026 | 40.52 Bn |
| Oct 24, 2025 | 40.95 Bn |
| Jul 25, 2025 | 41.03 Bn |
| Apr 25, 2025 | 41.66 Bn |
| Jan 24, 2025 | 38.87 Bn |
| Oct 25, 2024 | 39.79 Bn |
| Jul 26, 2024 | 39.67 Bn |
| Apr 26, 2024 | 38.20 Bn |
| Jan 26, 2024 | 37.43 Bn |
| Oct 27, 2023 | 36.66 Bn |
| Jul 28, 2023 | 37.70 Bn |
| Apr 28, 2023 | 36.92 Bn |
| Jan 27, 2023 | 40.21 Bn |
| Oct 28, 2022 | 40.84 Bn |
| Jul 29, 2022 | 36.88 Bn |
| Apr 29, 2022 | 36.17 Bn |
| Jan 28, 2022 | 37.67 Bn |
| Oct 29, 2021 | 39.33 Bn |
| Jul 30, 2021 | 39.84 Bn |